A House committee investigating the Chinese Communist Party (CCP) has demanded records from five major U.S. drugmakers about clinical trials in China that they participated in, citing studies the committee says involved hospitals in Xinjiang and medical sites tied to the Chinese military. Xinjiang has been a focus of U.S. government actions targeting Beijing on human rights and forced labor issues. Rep. John Moolenaar (R-Mich.), chairman of the House Select Committee on the CCP, sent letters dated June 29 to Merck, Pfizer, AbbVie, Eli Lilly, and Bristol Myers Squibb, according to documents obtained by The Epoch Times. The letters set a July 17 deadline for the companies to provide records on trial locations, informed consent, site inspections, data security, and licensing or joint-venture deals with Chinese biotechnology firms....